On Thursday I’m speaking at the Mayer Brown Life Sciences Symposium on AI, Blockchain, and Automation in the pharma industry. Here’s a graph from a recent EY Report showing the ways in which big data and automation will impact the pharma and healthcare industries.
These developments promise to revolutionize healthcare for the better. From a security perspective, these developments present both benefits and risks. On the risk side, one of the themes I’ll emphasize is the increased attack surface that comes from the integration of information across multiple vendors, devices, platforms, providers, and patients.